skip to Main Content

February 2, 2015

Codexis to Present at BIO CEO & Investor Conference

REDWOOD CITY, Calif., Feb. 2, 2015 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced that President and CEO John Nicols and Senior Vice President and CFO Gordon Sangster will present at the 17th Annual BIO CEO & Investor Conference on Monday, February 9, 2015, at 3:00 p.m. Eastern Time (12:00 p.m. Pacific Time). The conference is being held at the Waldorf Astoria in New York City.

A live webcast and replay will be available on the Investors section of the company’s website, http://ir.codexis.com/.

About Codexis, Inc.

Codexis, Inc. is a leading developer of biocatalysts for pharmaceutical and fine chemical production. Codexis’ proven technology enables scale-up and implementation of biocatalytic solutions to meet customer needs for rapid, cost-effective and sustainable process development – from research to manufacturing. For more information, see www.codexis.com.

CONTACT: Investors
  LHA
  Jody Cain, 310 691 7100
  jcain@lhai.com
  
  Media
 That’s Nice, LLC
 Guy Tiene, +1 212 366 4455
 

Guy@thatsnice.com


Codexis, Inc. logo

Codexis, Inc.

Back To Top
Close search
Search